Measurement of patient reported gastrointestinal (GI) and health-related quality of life (HRQL) outcomes in liver transplant recipients (MyLiver).

Trial Profile

Measurement of patient reported gastrointestinal (GI) and health-related quality of life (HRQL) outcomes in liver transplant recipients (MyLiver).

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Feb 2014

At a glance

  • Drugs Mycophenolate sodium (Primary)
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Acronyms MyLiver
  • Sponsors Novartis
  • Most Recent Events

    • 16 Jun 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Planned number of patients changed from 194 to 34 as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top